916420-44-5 Usage
Description
2-Chloro-6-(trifluoromethyl)benzoyl chloride is an organic compound that belongs to the family of benzoyl chlorides. It is characterized by the presence of a chlorine atom at the 2nd position and a trifluoromethyl group at the 6th position on the benzene ring. 2-Chloro-6-(trifluoromethyl)be is known for its reactivity and can be used in various chemical reactions and applications.
Uses
Used in Fluoro-chitin Derivatives Production:
2-Chloro-6-(trifluoromethyl)benzoyl chloride is used as a reagent for the production of fluoro-chitin derivatives. It reacts with chitin to form chitin derivatives with a high degree of substitution, which can be used in various applications such as drug delivery, tissue engineering, and material science.
Used in Homogenous Reactions:
2-Chloro-6-(trifluoromethyl)benzoyl chloride is used in homogenous reactions for the fluorination of chitin. The reaction is facilitated by diethyl amino sulfur trifluoride, which allows for the formation of fluoro-chitin derivatives with varying degrees of substitution.
Check Digit Verification of cas no
The CAS Registry Mumber 916420-44-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,6,4,2 and 0 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 916420-44:
(8*9)+(7*1)+(6*6)+(5*4)+(4*2)+(3*0)+(2*4)+(1*4)=155
155 % 10 = 5
So 916420-44-5 is a valid CAS Registry Number.
916420-44-5Relevant articles and documents
BICYCLIC HETEROCYCLIC COMPOUNDS AS ROR GAMMA MODULATORS
-
Page/Page column 41, (2015/02/02)
The present disclosure is directed to compounds of formula (I), and pharmaceutically acceptable salts thereof, as modulator of retinoid-related orphan receptor gamma t (RORγt). These compounds prevent, inhibit, or suppress the action of RORγt and are therefore useful in the treatment of RORγt mediated disease, disorder, syndrome or condition such as pain, inflammation, COPD, asthma, rheumatoid arthritis, colitis, multiple sclerosis, neurodegenerative diseases or cancer.
4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
-
Page/Page column 82; 83, (2014/03/22)
The present invention relates to compounds according to Formula I (Formula I), and pharmaceutically acceptable salts or solvates thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.
